Neratinib Reduced Recurrences, Diarrhea Problematic in Phase III ExteNET Study – OncLive


OncLive
Neratinib Reduced Recurrences, Diarrhea Problematic in Phase III ExteNET Study
OncLive
Treatment with neratinib immediately following adjuvant trastuzumab (Herceptin) plus chemotherapy modestly improved invasive disease-free survival (DFS) against placebo at the cost of low-grade diarrhea in almost all patients with HER2-positive …
Puma Biotechnology Announces Phase III Trial of PB272 in Extended Adjuvant MarketWatch
Puma Bio Breast Cancer Drug Given Rough Treatment at ASCO '15TheStreet.com
Puma Falls Again as Breast Cancer Drug Side Effects QuestionedBloomberg
OctaFinance.com
all 23 news articles »

diarrhea – Google News

Neratinib Reduced Recurrences, Diarrhea Problematic in Phase III ExteNET Study – OncLive


OncLive
Neratinib Reduced Recurrences, Diarrhea Problematic in Phase III ExteNET Study
OncLive
Treatment with neratinib immediately following adjuvant trastuzumab (Herceptin) plus chemotherapy modestly improved invasive disease-free survival (DFS) against placebo at the cost of low-grade diarrhea in almost all patients with HER2-positive …
Puma Biotechnology Announces Phase III Trial of PB272 in Extended Adjuvant MarketWatch
Puma Bio Breast Cancer Drug Given Rough Treatment at ASCO '15TheStreet.com
Puma Falls Again as Breast Cancer Drug Side Effects QuestionedBloomberg
OctaFinance.com
all 23 news articles »

diarrhea – Google News